Low-dose palliative radiotherapy for malignant peripheral T-cell lymphoma masked by cellulitis and osteomyelitis: a case report
BJR|Case Reports · 2023
DOI: 10.1093/bjrcr/uaad010 ↗Kurz gefasst
Fallbericht in der Zeitschrift BJR|Case Reports, 2023. Verfasst von Yasir Alayed. Beteiligte Einrichtung: Radiation Oncology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Classic Hodgkin lymphoma is a potentially curable disease. With the advent of effective systemic regimens with adriamycin, bleomycin, vincristine, and dacarbazine, chemotherapy has become the treatment of choice for advanced Hodgkin lymphoma. However, for advanced Hodgkin lymphoma after chemotherapy, disease relapse rates are still high. This case report highlights how low-dose palliative radiotherapy can be used successfully for the management of an unusual case of recurrent lymphoma with a different histology soon after completing systemic therapy, which was further complicated by an ongoing local infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiation Oncology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia.
Zitieren
APA
Alayed, Y. (2023). Low-dose palliative radiotherapy for malignant peripheral T-cell lymphoma masked by cellulitis and osteomyelitis: a case report. BJR|Case Reports. https://doi.org/10.1093/bjrcr/uaad010
Vancouver
Alayed Y. Low-dose palliative radiotherapy for malignant peripheral T-cell lymphoma masked by cellulitis and osteomyelitis: a case report. BJR|Case Reports. 2023. doi:10.1093/bjrcr/uaad010
BibTeX
@article{Alayed2023,
author = {Alayed, Yasir},
title = {Low-dose palliative radiotherapy for malignant peripheral T-cell lymphoma masked by cellulitis and osteomyelitis: a case report},
journal = {BJR|Case Reports},
year = {2023},
doi = {10.1093/bjrcr/uaad010}
}
EUVIMED